Clinical Trial Update: Covid-19 Vaccine Responsiveness in MM and Waldenstrom

View source ↗

Summary

Completed clinical trial update examining how patients with multiple myeloma and Waldenström macroglobulinemia respond to COVID-19 vaccination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Waldenström Macroglobulinemia

Drugs mentioned

• COVID-19 vaccine (COVID-19 vaccine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Multiple Myeloma, Waldenstrom Macroglobulinemia | Status: COMPLETED